サマリー

慢性疲労症候群治療薬の世界市場 2022-2026 年
Technavioは慢性疲労症候群治療薬市場を監視しており、2022-2026年の間に5184万ドル、予測期間中にCAGR4.31%で加速して成長する見通しです。当レポートでは、慢性疲労症候群治療薬市場について、全体的な分析、市場規模と予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、CFSに対する適応外薬理学的治療の増加、CFSのリスク要因の増加、CFSに関する認知度向上への取り組みが牽引しています。
慢性疲労症候群治療薬市場の分析には、製品セグメントと地理的展望が含まれます。
Technavioの慢性疲労症候群治療薬市場は、以下のようにセグメント化されています。
製品別
- 鎮痛剤とNSAIDs
- 抗うつ剤と抗精神病薬
- 抗菌薬、免疫調節薬
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間における慢性疲労症候群治療薬市場の成長を促進する主な理由の一つとして、CFSの新しい診断テストの開発を挙げています。また、CFS治療のための新薬の研究開発や、CFSにおける免疫系の役割の調査に注目が集まっていることも、市場の大きな需要につながっていくでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。慢性疲労症候群の治療薬市場に関する当レポートは、以下の分野を対象としています。
- 慢性疲労症候群治療薬市場のサイジング
- 慢性疲労症候群の治療薬市場予測
- 慢性疲労症候群治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AIM ImmunoTech社、Apotex社、Aurobindo Pharma社、Bionpharma社、Cadila Pharmaceuticals社、Hikma Pharmaceuticals Plc、Lupin Ltd、Pfizer Inc、Sun Pharmaceutical Industries Ltd、Teva Pharmaceutical Industries Ltd、Viatris Incなどの複数の主要慢性疲労症候群治療薬のベンダーに関する詳細分析を提供しています。また、慢性疲労症候群治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/chronic-fatigue-syndrome-therapeutics-market-industry-size-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Pain relievers and NSAIDs - Market size and forecast 2021-2026
o Exhibit 28: Chart on Pain relievers and NSAIDs - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Pain relievers and NSAIDs - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Pain relievers and NSAIDs - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Pain relievers and NSAIDs - Year-over-year growth 2021-2026 (%)
o 5.4 Antidepressant and antipsychotic drugs - Market size and forecast 2021-2026
o Exhibit 32: Chart on Antidepressant and antipsychotic drugs - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Antidepressant and antipsychotic drugs - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Antidepressant and antipsychotic drugs - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Antidepressant and antipsychotic drugs - Year-over-year growth 2021-2026 (%)
o 5.5 Antimicrobial and immunomodulatory drugs - Market size and forecast 2021-2026
o Exhibit 36: Chart on Antimicrobial and immunomodulatory drugs - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Antimicrobial and immunomodulatory drugs - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Antimicrobial and immunomodulatory drugs - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Antimicrobial and immunomodulatory drugs - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Product
o Exhibit 40: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 France - Market size and forecast 2021-2026
o Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 AIM ImmunoTech Inc.
o Exhibit 89: AIM ImmunoTech Inc. - Overview
o Exhibit 90: AIM ImmunoTech Inc. - Product / Service
o Exhibit 91: AIM ImmunoTech Inc. - Key offerings
o 10.4 Apotex Inc.
o Exhibit 92: Apotex Inc. - Overview
o Exhibit 93: Apotex Inc. - Product / Service
o Exhibit 94: Apotex Inc. - Key offerings
o 10.5 Bionpharma Inc.
o Exhibit 95: Bionpharma Inc. - Overview
o Exhibit 96: Bionpharma Inc. - Product / Service
o Exhibit 97: Bionpharma Inc. - Key offerings
o 10.6 Cadila Pharmaceuticals Ltd.
o Exhibit 98: Cadila Pharmaceuticals Ltd. - Overview
o Exhibit 99: Cadila Pharmaceuticals Ltd. - Business segments
o Exhibit 100: Cadila Pharmaceuticals Ltd. - Key offerings
o Exhibit 101: Cadila Pharmaceuticals Ltd. - Segment focus
o 10.7 Hikma Pharmaceuticals Plc
o Exhibit 102: Hikma Pharmaceuticals Plc - Overview
o Exhibit 103: Hikma Pharmaceuticals Plc - Business segments
o Exhibit 104: Hikma Pharmaceuticals Plc - Key offerings
o Exhibit 105: Hikma Pharmaceuticals Plc - Segment focus
o 10.8 Lupin Ltd.
o Exhibit 106: Lupin Ltd. - Overview
o Exhibit 107: Lupin Ltd. - Product / Service
o Exhibit 108: Lupin Ltd. - Key news
o Exhibit 109: Lupin Ltd. - Key offerings
o 10.9 Pfizer Inc.
o Exhibit 110: Pfizer Inc. - Overview
o Exhibit 111: Pfizer Inc. - Product / Service
o Exhibit 112: Pfizer Inc. - Key news
o Exhibit 113: Pfizer Inc. - Key offerings
o 10.10 Sun Pharmaceutical Industries Ltd.
o Exhibit 114: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 115: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 116: Sun Pharmaceutical Industries Ltd. - Key offerings
o 10.11 Teva Pharmaceutical Industries Ltd.
o Exhibit 117: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 118: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 119: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 120: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 121: Teva Pharmaceutical Industries Ltd. - Segment focus
o 10.12 Viatris Inc.
o Exhibit 122: Viatris Inc. - Overview
o Exhibit 123: Viatris Inc. - Business segments
o Exhibit 124: Viatris Inc. - Key offerings
o Exhibit 125: Viatris Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 126: Inclusions checklist
o Exhibit 127: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 128: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 129: Research methodology
o Exhibit 130: Validation techniques employed for market sizing
o Exhibit 131: Information sources
o 11.5 List of abbreviations
o Exhibit 132: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Pain relievers and NSAIDs - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Pain relievers and NSAIDs - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Pain relievers and NSAIDs - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Pain relievers and NSAIDs - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Antidepressant and antipsychotic drugs - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Antidepressant and antipsychotic drugs - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Antidepressant and antipsychotic drugs - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Antidepressant and antipsychotic drugs - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Antimicrobial and immunomodulatory drugs - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Antimicrobial and immunomodulatory drugs - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Antimicrobial and immunomodulatory drugs - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Antimicrobial and immunomodulatory drugs - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Product ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AIM ImmunoTech Inc. - Overview
Exhibits90: AIM ImmunoTech Inc. - Product / Service
Exhibits91: AIM ImmunoTech Inc. - Key offerings
Exhibits92: Apotex Inc. - Overview
Exhibits93: Apotex Inc. - Product / Service
Exhibits94: Apotex Inc. - Key offerings
Exhibits95: Bionpharma Inc. - Overview
Exhibits96: Bionpharma Inc. - Product / Service
Exhibits97: Bionpharma Inc. - Key offerings
Exhibits98: Cadila Pharmaceuticals Ltd. - Overview
Exhibits99: Cadila Pharmaceuticals Ltd. - Business segments
Exhibits100: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits101: Cadila Pharmaceuticals Ltd. - Segment focus
Exhibits102: Hikma Pharmaceuticals Plc - Overview
Exhibits103: Hikma Pharmaceuticals Plc - Business segments
Exhibits104: Hikma Pharmaceuticals Plc - Key offerings
Exhibits105: Hikma Pharmaceuticals Plc - Segment focus
Exhibits106: Lupin Ltd. - Overview
Exhibits107: Lupin Ltd. - Product / Service
Exhibits108: Lupin Ltd. - Key news
Exhibits109: Lupin Ltd. - Key offerings
Exhibits110: Pfizer Inc. - Overview
Exhibits111: Pfizer Inc. - Product / Service
Exhibits112: Pfizer Inc. - Key news
Exhibits113: Pfizer Inc. - Key offerings
Exhibits114: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits115: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits116: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits117: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits118: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits119: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits120: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits121: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits122: Viatris Inc. - Overview
Exhibits123: Viatris Inc. - Business segments
Exhibits124: Viatris Inc. - Key offerings
Exhibits125: Viatris Inc. - Segment focus
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations